These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37271203)

  • 1. Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology.
    Jeong WK; Kang HJ; Choi SH; Park MS; Yu MH; Kim B; You MW; Lim S; Cho YS; Lee MW; Hwang JA; Lee JY; Kim JH; Joo I; Bae JS; Kim SY; Chung YE; Kim DH; Lee JM
    Korean J Radiol; 2023 Jun; 24(6):482-497. PubMed ID: 37271203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review.
    Jeong WK
    J Liver Cancer; 2023 Sep; 23(2):272-283. PubMed ID: 37723641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.
    Maruyama H; Sekimoto T; Yokosuka O
    J Gastroenterol; 2016 May; 51(5):421-33. PubMed ID: 26694825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.
    Korean Society of Abdominal Radiology
    Korean J Radiol; 2017; 18(3):427-443. PubMed ID: 28458595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.
    Kudo M; Hatanaka K; Maekawa K
    Oncology; 2010 Jul; 78 Suppl 1():40-5. PubMed ID: 20616583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines.
    Kim TH; Yoon JH; Lee JM
    Korean J Radiol; 2019 Jun; 20(6):863-879. PubMed ID: 31132813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
    BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
    Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
    Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
    Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
    J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonazoid™ versus SonoVue
    Kang HJ; Lee JM; Yoon JH; Yoo J; Choi Y; Joo I; Han JK
    Korean J Radiol; 2022 Nov; 23(11):1067-1077. PubMed ID: 36196767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
    Hwang JA; Jeong WK; Kang HJ; Lee ES; Park HJ; Lee JM
    Eur Radiol; 2022 Dec; 32(12):8507-8517. PubMed ID: 35705829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline.
    Kang HJ; Lee JM; Kim SW
    Ultrasonography; 2023 Oct; 42(4):479-489. PubMed ID: 37423603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
    Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast enhanced ultrasound of hepatocellular carcinoma.
    Numata K; Luo W; Morimoto M; Kondo M; Kunishi Y; Sasaki T; Nozaki A; Tanaka K
    World J Radiol; 2010 Feb; 2(2):68-82. PubMed ID: 21160920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
    J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound.
    Park HJ; Jang HY; Kim SY; Lee SJ; Won HJ; Byun JH; Choi SH; Lee SS; An J; Lim YS
    J Hepatol; 2020 Apr; 72(4):718-724. PubMed ID: 31836549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound Evaluation in Patients at Risk for Hepatocellular Carcinoma.
    Fetzer DT; Rodgers SK; Seow JH; Dawkins AA; Joshi G; Gabriel H; Kamaya A
    Radiol Clin North Am; 2019 May; 57(3):563-583. PubMed ID: 30928078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT.
    Hatanaka K; Kudo M; Minami Y; Maekawa K
    Oncology; 2008; 75 Suppl 1():42-7. PubMed ID: 19092271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods.
    Han S; Kim SW; Park S; Yoon JH; Kang HJ; Yoo J; Joo I; Bae JS; Lee JM
    Ultrasound Med Biol; 2023 Oct; 49(10):2256-2263. PubMed ID: 37495497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.